Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.

Di LuZhihang HuHao ChenAbid Ali KhanQingguo XuZuyuan LinHuigang LiJianyong ZhuoChiyu HeLi ZhuangZhe YangSiyi DongJinzhen CaiShusen ZhengXiao Xu

Published in: Journal of cachexia, sarcopenia and muscle (2024)

Pre-transplant myosteatosis aggravated the adverse impact of sarcopenia on liver transplant outcomes in male HCC patients. Post-transplant muscle loss might assist in prognostic stratification of recipients without pre-existing sarcopenia, intriguing new insights into individualized management.

Keyphrases

skeletal muscle
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
emergency department
type diabetes
metabolic syndrome
patient reported outcomes
adverse drug